Company Information & Drug Savings for Basilea Pharmaceutica Ltd. Medications
Basilea Pharmaceutica is a Swiss biopharmaceutical company focused on developing anti-infective and oncology treatments. The company created Cresemba (isavuconazole), a broad-spectrum antifungal for invasive aspergillosis and mucormycosis, and Zevtera (ceftobiprole) for hospital-acquired bacterial pneumonia. Basilea addresses critical unmet needs in serious fungal and bacterial infections resistant to standard treatments.
How to Contact Basilea Pharmaceutica Ltd.
Phone
1-781-522-6800Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
